RVLP Annual Working Capital
$37.25 M
-$2.02 M-5.14%
31 December 2022
Summary:
As of February 5, 2025, RVLP annual working capital is $37.25 million, with the most recent change of -$2.02 million (-5.14%) on December 31, 2022. During the last 3 years, it has fallen by -$59.44 million (-61.47%).RVLP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP Quarterly Working Capital
-$42.64 M
-$64.58 M-294.31%
30 June 2023
Summary:
As of February 5, 2025, RVLP quarterly working capital is -$42.64 million, with the most recent change of -$64.58 million (-294.31%) on June 30, 2023. Over the past year, it has dropped by -$64.27 million (-297.10%).RVLP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -5.1% | -297.1% |
3 y3 years | -61.5% | -133.3% |
5 y5 years | +478.2% | -418.4% |
RVLP Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | -68.3% | -132.4% |
RVL Pharmaceuticals Working Capital History
Date | Annual | Quarterly |
---|---|---|
June 2023 | - | -$42.64 M(-294.3%) |
Mar 2023 | - | $21.94 M(-41.1%) |
Dec 2022 | $37.25 M(-5.1%) | $37.25 M(-24.6%) |
Sept 2022 | - | $49.43 M(+128.5%) |
June 2022 | - | $21.63 M(-43.1%) |
Mar 2022 | - | $38.04 M(-3.1%) |
Dec 2021 | $39.27 M(-66.5%) | $39.27 M(-228.6%) |
Sept 2021 | - | -$30.55 M(+90.6%) |
June 2021 | - | -$16.03 M(-114.2%) |
Mar 2021 | - | $112.70 M(-4.0%) |
Dec 2020 | $117.37 M | $117.37 M(-3.2%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2020 | - | $121.22 M(-5.2%) |
June 2020 | - | $127.90 M(-2.7%) |
Mar 2020 | - | $131.51 M(+36.0%) |
Dec 2019 | $96.69 M(+65.7%) | $96.69 M(+9.0%) |
Sept 2019 | - | $88.71 M(+16.6%) |
June 2019 | - | $76.07 M(+12.7%) |
Mar 2019 | - | $67.47 M(+15.6%) |
Dec 2018 | $58.36 M(-692.5%) | $58.36 M(+73.2%) |
Sept 2018 | - | $33.70 M(+151.7%) |
June 2018 | - | $13.39 M(-235.9%) |
Dec 2017 | -$9.85 M(-58.3%) | -$9.85 M |
Dec 2016 | -$23.62 M | - |
FAQ
- What is RVL Pharmaceuticals annual working capital?
- What is the all time high annual working capital for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals annual working capital year-on-year change?
- What is RVL Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals quarterly working capital year-on-year change?
What is RVL Pharmaceuticals annual working capital?
The current annual working capital of RVLP is $37.25 M
What is the all time high annual working capital for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high annual working capital is $117.37 M
What is RVL Pharmaceuticals annual working capital year-on-year change?
Over the past year, RVLP annual working capital has changed by -$2.02 M (-5.14%)
What is RVL Pharmaceuticals quarterly working capital?
The current quarterly working capital of RVLP is -$42.64 M
What is the all time high quarterly working capital for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high quarterly working capital is $131.51 M
What is RVL Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, RVLP quarterly working capital has changed by -$64.27 M (-297.10%)